• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

May 7, 2019

View Archived Issues

Novel selective PI3Kgamma inhibitors induce specific conformational changes

Read More

Myelin from hair stem cells

Read More

Small-molecule HDAC6 inhibitor improves memory and learning in fragile X syndrome in vivo

Read More

Orally active small molecule against influenza A hemagglutinin mimicking a broadly neutralizing Ab

Read More

AlzeCure redirects development of ACD-855 from cognition to eye indication

Read More

By itself, GITR stimulation can't "GIT'R done"

Read More

Targeting metabolism prevents epilepsy after TBI

Read More

KalVista presents data on PKa inhibitors for retinal edema

Read More

Antitumor activity of IC9-Luc90-CD828Z demonstrated in vitro

Read More

Huntington's hopefuls present at AAN 2019

Read More

FDA clears OnKure's IND to initiate phase I studies of OKI-179

Read More

Daewoong Pharmaceutical patents BTK and ITK dual inhibitors

Read More

Adaptimmune announces clinical progress with ADP-A2M4 in synovial sarcoma and other solid tumors

Read More

FDA approves Vyndaqel and Vyndamax for the treatment of cardiomyopathy caused by ATTR-CM

Read More

Gilead Sciences divulges new HIV protease inhibitors

Read More

Esteve Pharmaceuticals presents new analgesics

Read More

Shanghai Longwood Biopharmaceuticals identifies PD-1/PD-L1 inhibitors

Read More

Skyhawk and Takeda collaborate to develop small-molecule treatments for neurodegenerative diseases

Read More

European Commission approves Palynziq to treat PKU

Read More

Sunshine Lake Pharma divulges compounds for HBV infections

Read More

Onxeo treats first patient in phase Ib study of AsiDNA for solid tumors

Read More

Verona initiates phase IIb study of nebulized ensifentrine in moderate to severe COPD

Read More

DSMB recommends continuation of phase I/II PIONEER study of GS-030 in retinitis pigmentosa

Read More

Axsome announces expedited development and pivotal status for AXS-05 for the treatment of MDD

Read More

First patient dosed in phase I DUET-3 study of XmAb-23104

Read More

Phase III trial of Epidiolex in TSC meets primary endpoint

Read More

CytoDyn reports data from leronlimab monotherapy study

Read More

Simple, reversible mouse model mimics secondary glaucoma

Read More

FDA approves Ruzurgi for pediatric patients with Lambert-Eaton myasthenic syndrome

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • 3D heart in chest

    At CRVBC 2025: Aging is circulating in your blood

    BioWorld Science
    All kinds of substances circulate through the bloodstream. Some are beneficial, like oxygen or nutrients, and others less so, like waste products, toxins,...
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe